Podcasts about senior medical director

In this episode of Moving Medicine Forward, we sit down with Dr. Helios Tedesco, a globally recognized transplant nephrologist from São Paulo, Brazil, who leads one of the world's largest kidney transplant programs. Joined by CTI experts Dr. Christopher Boshkos, Senior Medical Director, and Clinical Scientist, Erika Aldag, the conversation explores the challenges and innovations behind managing more than 15,000 transplant patients, from telehealth expansion and donor matching to cutting-edge immunosuppressive strategies and the future of surveillance tools such as cell-free DNA and the iBox model. This episode offers a rare look into the science, systems, and human dedication driving transplant care forward. 00:00 Host Jeremy Strand introduces the podcast and this episode's focus on transplant innovation.  00:35 Dr. Helios Tedesco (São Paulo), Dr. Christopher Boshkos, and Clinical Scientist Erika Aldag join to discuss global kidney transplant practices.  01:13 Dr. Tedesco shares his background, highlighting nearly 40 years in nephrology, performing over 1,000 kidney transplants annually, and a strong foundation in research.  03:17 Managing large transplant populations involves strategic follow-up care, decentralized nephrology networks, and an expanding role for telehealth.  06:30 How patients are matched to regimens, minimizing rejection and addressing regional challenges.  11:49 Dr. Tedesco explains their one-dose thymoglobulin approach and its benefits over traditional multi-dose methods.  18:34 New tools for monitoring graft health include donor-derived cell-free DNA, advanced biopsy techniques, and an examination of barriers to widespread adoption.  24:25 Discussion on the potential of the iBox model as a predictive tool for clinical trials and long-term graft survival.  28:15 Transplant science is headed toward improved long-term therapies, innovative biologics, and more patient-friendly immunosuppression options.  32:15 Successes and learnings from scaling telehealth to support a large patient base.  37:41 Appreciation for the collaboration between CTI and global transplant centers. 

In this episode, we're joined by Dave Hughes, PharmD, BCOP, MPH, Senior Medical Director at Pfizer, who shares his expertise on the clinical trial landscape. With years of experience in oncology research and clinical pharmacy, Dave breaks down the key phases of clinical trials—from early-stage safety assessments to confirming effectiveness in large populations. Understanding these phases is essential for anyone involved in the drug development process.Dave also delves into the growing role of real-world evidence, which offers valuable insights into how therapies perform in everyday clinical settings, complementing traditional clinical trial data. He discusses how FDA approval pathways, such as fast track, breakthrough therapy, and accelerated approval, are designed to expedite access to life-saving therapies.We also explore the future of clinical trials, from AI and machine learning's transformative impact on research to the evolving strategies that will shape patient care. Finally, Dave addresses the common misconception that clinical trials are only available as a last resort, emphasizing that they offer early access to cutting-edge treatments throughout a patient's journey. Disclaimer:The views and opinions expressed in this episode are solely those of our guest, Dave, and do not represent the official stance, policies, or views of Pfizer, NCODA, or any other organization. This discussion is for informational purposes only and should not be considered medical or regulatory advice. Always consult with regulatory authorities for official guidance.

In this VETgirl online veterinary continuing education podcast, in recognition of National Poison Prevention Week, we interview Dr. Tina Wismer, MS, DABVT, DABT, Senior Medical Director at the ASPCA Animal Poison Control Center, based out of Urbana, Illinois about the biggest toxicology updates veterinary professionals need to be aware of! Tune in to learn the evidence-based, clinically applicable toxicology updates that save lives... from the difference between activated charcoal and cholestyramine to using fluid therapy in the poisoned patient, you'll want to tune in!Sponsored By:

In this episode, Kelsey Smith, Senior Director of Care Management and Behavioral Health Services at Providence Swedish, and Jenni O'Donnell, Senior Medical Director of Behavioral Health Integration at Swedish Medical Group, discuss the critical importance of caregiver well-being. They explore the impact of burnout, innovative support programs, and the future of well-being initiatives aimed at fostering resilience and retention in healthcare.

In this series, we're exploring the balance between what you can and can't control when it comes to your health.On this episode, Chuck Gaidica is joined by Senior Medical Director for Blue Cross Blue Shield of Michigan, Dr. Raymond Hobbs. Together, they explore how to embrace the natural aging process while focusing on the areas of our health we can actively maintain.In this episode of A Healthier Michigan Podcast, we explore:How lifestyle habits like diet, exercise, and avoiding tobacco can significantly impact aging and health through epigenetic changes.How activities that stimulate the mind, like learning new skills, are important for maintaining cognitive function.How building physical and mental resilience through things like social connections, purpose, and managing stress are crucial for healthy aging.How regular checkups with a doctor to monitor and address health risks are recommended, even if you feel healthy.Heading into our final episode of this series, we'll look at the role of lifestyle in disease prevention – especially when faced with risk factors beyond our control. Join us to learn how small changes we make today can help protect our health in the long run

Today, you're getting a masterclass about what alcohol does to your body, brain, and health. One of the most renowned and respected experts on alcohol is here to give you the latest research and science of how alcohol impacts your life. She's going to give you facts and help you be informed about the decisions you are making when it comes to your mental, physical, and emotional health when it comes to alcohol consumption. Joining Mel today is Harvard's Dr. Sarah Wakeman, MD. Dr. Wakeman is Senior Medical Director of Substance Use Disorder at Mass General Brigham, an Associate Professor of Medicine at Harvard Medical School, and the Program Director of Mass General Substance Use Addiction Services. She's here to answer: How much is TOO much alcohol? What amount of alcohol is okay in a healthy life? What happens to your brain when you drink? And how do you help someone you love who you think drinks too much? By the time you finish listening, you'll have the latest research so that you make the most informed decisions about the role alcohol plays in your life. This is an encore episode with new and exciting insights from Mel at the top. Join Mel on her first ever LIVE tour, Let Them The Tour, here.Get a copy of Mel's new book, The Let Them Theory here. For more resources, including links to Dr. Sarah Wakeman's work, click here for the podcast episode page. If you liked this episode, your next listen should be this one: Harvard Psychologist Shares 6 Words That Will Change Your Family Connect with Mel:  Get Mel's new book, The Let Them TheoryWatch the episodes on YouTubeFollow Mel on Instagram The Mel Robbins Podcast InstagramMel's TikTok Sign up for Mel's personal letter Subscribe to SiriusXM Podcasts+ on Apple Podcasts to listen to ad-free new episodes Disclaimer

In our January episode, we got to know Dr. Lela Mayers, the Benefit Funds' new Deputy Chief Medical Officer. In this month's Key Note, Dr. Mayers discusses the wide range of wellness resources members can take advantage of to support them on their health journeys.   The Takeaway We want to hear from you! Drop us a line at our social media channels: Facebook// Instagram // YouTube Start your health journey by making an appointment with your primary care physician. Visit our Healthy Living Resource Center for wellness tips, information and resources; 1199SEIUBenefits.org/healthyliving. Talk to your doctor about any screenings you may need: 1199SEIUBenefits.org/healthybodies. Know your numbers to find out where you stand: 1199SEIUBenefits.org/healthyhearts. Get inspired by fellow members through our Members' Voices series: www.1199SEIUBenefits.org/healthyliving/membervoices. Stop by our Benefits Channel to view webinars on managing stress, building healthy meals and more: www.1199SEIUBenefits.org/videos. Visit our YouTube Channel to view a wide collection of healthy living videos: youtube.com/@1199SEIUBenefitFunds/playlists Sample our wellness classes to exercise body and mind: www.1199SEIUBenefits.org/wellnessevents. Guest Bio Dr. Lela Mayers is the Deputy Chief Medical Officer (DCMO) of the 1199SEIU Benefit Funds, which provide comprehensive self-insured, self-administered healthcare benefits to more than 450,000 healthcare workers, retirees and their families. As DCMO, Dr. Mayers assists the Chief Medical Officer with the Benefit Funds' clinical and care management strategies, as well as health and wellness initiatives. Prior to joining the Benefit Funds, Dr. Mayers served as Senior Medical Director at CVS Health/Aetna. There she collaborated with the account management teams, pharmacy teams, consulting firms and plan sponsors to drive improved health outcomes for commercial and labor health plan members. Prior to that, she served as Chief of Medicine at Premier Healthcare, where she managed five ambulatory health centers across New York City. Her previous experience with union membership was earned at the Benefit Fund of the New York Hotel Trades, where she was medical director of the Harlem Health Center. Dr. Mayers worked for many years as a primary care physician at the Farrell Health Center of NewYork-Presbyterian Hospital, where she served as faculty and medical director of the resident training program. Dr. Mayers continues to hold a position as voluntary faculty/instructor in clinical medicine at Columbia University's Center for Family and Community Medicine. She is a licensed physician in New York State and is board certified with the American Board of Family Medicine. Dr. Mayers received a Bachelor of Arts from Cornell University, a Doctor of Medicine from Cornell University Medical College (now Weill Cornell Medical College) and a Master of Public Health from the Mailman School of Public Health at Columbia University.

In this episode, we sit down with Dr. Lela Mayers, the Benefit Funds' Deputy Chief Medical Officer (DCMO). Dr. Mayers recently joined us to work alongside Chief Medical Officer Dr. Van Dunn in supporting our members' health journeys. In our conversation, we get to know more about our new DCMO, who began her career as a family medicine physician. Among other things, we learn what she loved about family medicine, why she made the transition to her current role at the Benefit Funds, why it's so important for healthcare workers to make their own health a priority, what she's learned from walking in our members' shoes and what she looked for when she found the perfect doctor for her parents – and what we can all look for, too. The Takeaway Start your health journey by making an appointment with your primary care physician. Visit our Healthy Living Resource Center for wellness tips, information and resources; 1199SEIUBenefits.org/healthyliving. Talk to your doctor about any screenings you may need: 1199SEIUBenefits.org/healthybodies. Know your numbers to find out where you stand: 1199SEIUBenefits.org/healthyhearts. Get inspired by fellow members through our Members' Voices series: www.1199SEIUBenefits.org/healthyliving/membervoices. Stop by our Benefits Channel to view webinars on managing stress, building healthy meals and more: www.1199SEIUBenefits.org/videos. Visit our YouTube Channel to view a wide collection of healthy living videos: youtube.com/@1199SEIUBenefitFunds/playlists Sample our wellness classes to exercise body and mind: www.1199SEIUBenefits.org/wellnessevents. We want to hear from you! Drop us a line at our social media channels: Facebook // Instagram // YouTube Guest Bio Dr. Lela Mayers is the Deputy Chief Medical Officer (DCMO) of the 1199SEIU Benefit Funds, which provide comprehensive self-insured, self-administered healthcare benefits to more than 450,000 healthcare workers, retirees and their families. As DCMO, Dr. Mayers assists the Chief Medical Officer with the Benefit Funds' clinical, care management and analytics functions, as well as health and wellness initiatives and value-based strategies. Prior to joining the Benefit Funds, Dr. Mayers served as Senior Medical Director at CVS Health/Aetna. There she collaborated with the account management teams, pharmacy teams, consulting firms and plan sponsors to drive improved health outcomes for commercial and labor health plan members. Prior to that, she served as Chief of Medicine at Premier Healthcare, where she managed five ambulatory health centers across New York City. Her previous experience with union membership was earned at the Benefit Fund of the New York Hotel Trades, where she was medial director of the Harlem Health Center. Dr. Mayers worked for many years as a primary care physician at the Farrell Health Center of NewYork-Presbyterian Hospital, where she served as faculty and medical director of the resident training program. Dr. Mayers continues to hold a position as voluntary faculty/instructor in clinical medicine at Columbia University's Center for Family and Community Medicine. She is a licensed physician in New York State and is board certified with the American Board of Family Medicine. Dr. Mayers received a Bachelor of Arts from Cornell University, a Doctor of Medicine from Cornell University Medical College (now Weill Cornell Medical College) and a Master of Public Health from the Mailman School of Public Health at Columbia University.

The holidays can be a stressful time for everyone, especially those with dementia and their care partners. In preparation for this season, Dr. Alexis Eastman joins Dementia Matters for our last episode of 2024. Drs. Chin and Eastman discuss strategies for managing the potential stress of holiday traveling and gatherings, important safety considerations and more. Guest: Alexis Eastman, MD, geriatrician, Senior Medical Director of Ambulatory Medical Specialties, UW Health, associate clinical professor, Division of Geriatrics and Gerontology, University of Wisconsin School of Medicine and Public Health Show Notes Listen to our past episode with Dr. Eastman, “Holiday Tips for Dementia Caregivers,” on our website. Find more resources and tips for the holidays in “Resources for navigating the holidays with Alzheimer's” on our website. Want to support Dementia Matters? Make an end-of-year gift to the Dementia Matters fund through the UW Initiative to End Alzheimer's. Connect with us Find transcripts and more at our website. Email Dementia Matters: dementiamatters@medicine.wisc.edu Follow us on Facebook and Twitter. Subscribe to the Wisconsin Alzheimer's Disease Research Center's e-newsletter. Enjoy Dementia Matters? Consider making a gift to the Dementia Matters fund through the UW Initiative to End Alzheimer's. All donations go toward outreach and production.

Interview with Michael Mithoefer  Michael Mithoefer, M.D., is a psychiatrist living in Asheville, NC, with a research office in Charleston, SC. In 2000, he began collaborating with MAPS on the first U.S. Phase 2 clinical trial of MDMA-assisted psychotherapy. He and his wife Annie have since conducted two of the six MAPS-sponsored Phase 2 clinical trials testing MDMA-assisted psychotherapy for PTSD, as well a study providing MDMA-assisted sessions for therapists who have completed the MAPS-sponsored MDMA Therapy Training Program, and a pilot study treating couples with MDMA-assisted psychotherapy combined with Cognitive-Behavioral Conjoint Therapy. He is now Senior Medical Director for Medical Affairs, Training and Supervision at MAPS Public Benefit Corporation (MAPS PBC). He is a Grof-certified Holotropic Breathwork Facilitator, is trained in EMDR and Internal Family Systems Therapy, and has nearly 30 years of experience treating trauma patients. Before going into psychiatry in 1991, he practiced emergency medicine for ten years, served as medical director of the Charleston County and Georgetown County Emergency Departments, and has held clinical faculty positions at the Medical University of South Carolina. He has been board-certified in Psychiatry, Emergency Medicine, and Internal Medicine.

In the midst of the COVID-19 pandemic, The Centers for Medicare & Medicaid services released the Acute Hospital Care at Home payment waiver. The action was expected to usher in a new era of home-based care. But while it's certainly grown in recent years, frankly, that massive shift hasn't happened. The question is, why? This week, host Abby Burns invites Dr. Matthew Richards, Senior Medical Director of home-care enablement company Medically Home, to explore the role that home-base care could play in the future of healthcare, and to unpack the misconceptions that prevent home-based care from playing a larger role in the healthcare ecosystem today. Links: Home - Medically Home 5 trends (re)shaping site-of-care shifts The future of the acute care at home model Ep. 64: Why Contessa's CEO believes hospital at home benefits everyone (including hospitals) Strategic Planner's survey 2024 Survey insights: 6 priorities for health system strategists in 2024 A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.

Can employers really transform health care quality and costs? Join us in the miniVHAN for an eye-opening conversation with Michael Kobernick, MD, Senior Medical Director at Blue Cross Blue Shield of Michigan, as he unpacks the evolving roles of employers and brokers in the health care ecosystem. Dr. Kobernick draws upon his experience both in the practice of medicine and in critical health care leadership to imagine how employers can more successfully collaborate with provider organizations.  Tune in to understand how value-based care models can lead to healthier communities by removing patients' social and financial barriers. You'll also discover how businesses, regardless of size, can shift the focus from merely cutting expenses to genuinely enhancing their employees' health. 

Join Jakob Emerson as he converses with Dr. Matthew Hurford, Dr. Matthew Hurford, President and CEO of Community Care Behavioral Health Organization (part of UPMC Health Plan) and Dr. Michael Lynch, Senior Medical Director, Quality and Substance Use Disorder Services at UPMC Health Plan. They discuss the transformative Telemedicine Bridge Clinic model and its impact on patients with substance use disorders, highlighting clinical outcomes, patient engagement, and the broader ecosystem of care essential for holistic health and wellness.

Got Something to Say? is brought to you by United Federal Credit Union - We Get U!  Jonny Reinhardt talks with Dr. Dan Waxman, Vice President and Senior Medical Director from Versiti Blood Centers of Michigan about Michigan Experiencing Emergency Blood Shortage. To meet the needs of hospitals and ensure they have enough blood for patients, 4,000 donors are urgently needed in the next seven days.See omnystudio.com/listener for privacy information.

—- 

In the lead up to ASCO 2024, we hosted a discussion on the dynamic landscape of oncology today, looking through the lens of this year's meeting theme: the art and science of cancer care. Within two featured mini panels, we reviewed key trends and innovations and highlighted how intersections between art and science can help us change the face and future of the cancer experience. Touching on areas like advocacy, AI, screening and therapeutic advances, this can't miss conversation will help us envision a more effective and compassionate future in oncology.   The Art: The art of improving patient care. How industry collaborations, data-based messaging and campaigns and advocacy are helping to reach more patients earlier and more holistically. Ysabel Duron, Founder, President / Executive Director, The Latino Cancer Institute  Meredith Owen, Chief Revenue Officer, Analytics & Insights Group, Real Chemistry Shanthi Sivendran, MD, MSCR, MBA, Senior Vice President, Cancer Care Support, American Cancer Society    The Science: The latest therapeutics advancements in oncology. How technology is helping industry better engage providers and democratize science via visualization to help improve outcomes. HP Balaji, Senior Medical Director and TA Head, Bladder Cancer, Johnson & Johnson Innovative Medicine Brandon Pletsch, President, Scientific Visualization and Exhibit Experience, Real Chemistry

Dr. Joy is the Chief Medical Officer for Lore Health. Prior to that, she served as Senior Medical Director for Wellness and Nutrition at Intermountain Health in Salt Lake City, UT. She received her B.S. and M.D. degrees at the University of Minnesota, and M.P.H. from the University of Utah. She completed her Family Medicine Residency and Sports Medicine Fellowship at Hennepin County Medical Center in Minneapolis, MN. She is an adjunct faculty member at the University of Utah School of Medicine in the Department of Family and Preventive Medicine, and in the College of Health Department of Nutrition & Integrative Physiology. Dr. Joy is the Past President of the American College of Sports Medicine (ACSM), and the Female Athlete Triad Coalition. She Chairs the Exercise Is Medicine Governance Committee for the ACSM, and serves on the Board of Directors, and Chairs the Healthcare Sector for the National Physical Activity Plan. Her research interests lie in the areas of diabetes prevention, physical activity promotion, and the Female Athlete Triad.For information about my upcoming Online Yoga For Dudes, Brand-New Beginner's Course - email me directly at jpanasevich@gmail.com, or call or text me at 267.275.3890.

Dr. Shaquita Bell (Pediatrics; Senior Medical Director, Odessa Brown Clinic) gives guidance on how to increase collaboration with clinical communities. Start by reaching out and listening to nearby community members or organizations. Ensure compensation and decision making roles for members, and target outreach events to their needs and interests. Finally, learn what to do if you make a mistake, how to continuously build trust in these partnerships, and what it looks like to successfully create solutions together. Music by Kevin MacLeod (https://incompetech.com/)

Breast cancer is the most common type of cancer among women worldwide, and it can be treated with different modalities, such as surgery, chemotherapy, radiation, hormone therapy and targeted therapy. However, even after the primary treatment, some cancer cells may remain in the body and cause recurrence or metastasis. This is where adjuvant therapies come in: they are additional treatments that aim to reduce the risk of cancer coming back or spreading to other parts of the body.In this episode, Syneos Health colleagues Dr. Juan Manuel Carrera, Senior Medical Director and Lisamarie Burgio, Executive Director, Therapeutic Strategy and Innovation join the podcast to explore the role of adjuvant therapies in breast cancer, with a focus on the latest developments and challenges in this field. They share their extensive experiences and insights from both clinical and operational perspectives, emphasizing the importance of personalized treatment approaches based on the latest genomic information and the evolving landscape of clinical trials, offering a comprehensive view of the strides being made and the challenges that remain. For the latest oncology insights from our experts, check out: Bridging the Gap in Male Breast Cancer Research Through Inclusive Clinical Trial StrategyOncology and the Evolution of Master Clinical Trials | Lessons from the Beat AML Master TrialReadiness Assessment: What Strategies Can You Deploy to Improve Diversity in Your Oncology Trials?Syneos Health Podcast | The Case for Genetic MedicineIs Your NSCLC Asset Ready to Create Value Post-FDA Approval? | 2024 UpdateThe views expressed in this podcast belong solely to the speakers and do not represent those of their organization. If you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you'll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision-making and investment. You can find it all at insightshub.health. Like what you're hearing? Be sure to rate and review us! We want to hear from you! If there's a topic you'd like us to cover on a future episode, contact us at podcast@syneoshealth.com.

Dementia is a complex topic that requires a delicate balance of understanding, compassion, and expertise. With the prevalence of dementia on the rise, healthcare providers, caregivers, and individuals themselves must have a solid grasp on how to navigate these challenging conditions. Our guest Brent Forester is an expert in geriatric psychiatry and dementia care, bringing almost three decades of experience supporting individuals with dementia and older adults facing mental health challenges. Discussing his co-authorship with Tom Harrison of "The Complete Family Guide to Dementia: Everything You Need to Know to Help Your Parent and Yourself", we hear about his proactive approach to caregiving and education for families and his journey into geriatric psychiatry. Through his insights into the nuances of dementia care, early diagnosis, treatment, the importance of distinguishing between various types of dementia, and grief in caregiving, Brent guides us in developing resilience and adapting to the emotional complexities of caring for a loved one with dementia.   Listen and Learn:  The admiration for his role model grandmother and fascination with problem-solving in medicine that influenced Brent's career in Geriatric psychiatry  The process of diagnosing dementia and the benefits of early diagnosis The difference between the clinical syndrome, which we call dementia, and the disease of dementia What are the causes and symptoms of dementia?  The multifaceted challenges dementia presents and the need for comprehensive healthcare approaches that consider these complexities Goal setting and the importance of self-care for caregivers of people suffering from dementia  Resources:  More about Brent: The Complete Family Guide to Dementia: Everything You Need to Know to Help Your Parent and Yourself About Brent P. Forester Brent P. Forester, MD, MSc. is the Dr. Frances S. Arkin Professor and Chair of Psychiatry at Tufts University School of Medicine, Psychiatrist in Chief and Chairman for the Department of Psychiatry at Tufts Medical Center and Director of Behavioral Health for Tufts Medicine.  Dr. Forester spent a quarter of a century of his professional career at McLean Hospital and Mass General Brigham where he served as the Chief of the Division of Geriatric Psychiatry at McLean Hospital and Senior Medical Director for Value Based Care Solutions in the Population Health Management department at Mass General Brigham. Dr. Forester is an expert in geriatric psychiatry, specializing in the treatment of older adults with depression, bipolar disorder, and behavioral complications of Alzheimer's disease and related dementias. He is a Past President of the American Association for Geriatric Psychiatry (AAGP), a distinguished fellow of the American Psychiatric Association, and has previously served on the board of directors of the Alzheimer's Association of Massachusetts/New Hampshire and chair of their Medical Scientific Committee. Dr. Forester's research focuses on novel treatment approaches to manage the disabling behavioral complications of dementia, such as agitation and aggression. Dr. Forester's work also includes the implementation and evaluation of collaborative care models for comprehensive dementia care within primary care medical settings Related Episodes: A Family Guide to Dementia 338. ACT for Burnout with Debbie! 207. Burnout with Debbie and Jill 204. Ageless with Andrew Steele 13. Healthy Aging and the Brain Learn more about your ad choices. Visit megaphone.fm/adchoices

Join us for an engaging episode with Dr. Leslie Wong, Senior Medical Director of Medical Specialties at Intermountain Health. Dr. Wong shares insights into his background, impactful changes in the past year, current healthcare trends, and growth strategies for the next 12-24 months. Tune in to gain valuable perspectives on medical specialties and the evolving landscape of healthcare.

Salome Juethner, Senior Medical Director, Head of Rare Genetics, and Interim Head of Rare GI at Takeda, discusses HAE, hereditary angioedema, a rare genetic disorder that causes painful and unpredictable swelling attacks that can be life-threatening. Salome emphasizes the need to educate physicians to consider HAE as a potential diagnosis in children as young as two years old and underrepresented racial and ethnic groups. To treat HAE, Takeda offers Takhzyro, a medication that can be used on-demand and as a preventative therapy, administered at home through a subcutaneous injection.  Salome explains, "Hereditary angioedema, or HAE, is a rare genetic disorder with a prevalence of one in 50,000. It can cause very painful, unpredictable swelling attacks that can occur in the throat, abdomen, hands, feet, and face. And as you can imagine, a throat attack could be potentially life-threatening. There are different triggers for these attacks. Some can just be stress and that could be positive stress like a wedding or going to prom or an illness and others. It can be quite limiting when you have to live thinking if I do something, is that going to trigger an attack? The symptoms can change over time, and HAE may not necessarily look the same for each person. Typically, people with HAE are missing an important protein in their blood called a C1 inhibitor. Either they're missing it or have very low levels, and it just may not work the way it should." "For people who have never heard of HAE, things get a lot more difficult because they rely on their physician, who may or may not be aware of this very rare disease and consider it part of the differential diagnosis. So it is not uncommon to hear patients talk about going for years before they ever got their diagnosis and that they were experiencing symptoms during that time, going to the emergency room, and maybe even being misdiagnosed with another condition until they finally saw someone who thought, oh, you know what? We should screen you for HAE." "Screening is really just a blood test. So, you would screen for a C4 level, which would be low or normal. If you're thinking about whether this could be HAE, then you would go ahead and check a C1 inhibitor level and a functional C1 level, and then those would be low as well. It's really about educating people, though, to consider it as part of the differential diagnosis."  #Takeda #HAE #HereditaryAngioedema #RareDisease takeda.com Download the transcript here

Salome Juethner, Senior Medical Director, Head of Rare Genetics, and Interim Head of Rare GI at Takeda, discusses HAE, hereditary angioedema, a rare genetic disorder that causes painful and unpredictable swelling attacks that can be life-threatening. Salome emphasizes the need to educate physicians to consider HAE as a potential diagnosis in children as young as two years old and underrepresented racial and ethnic groups. To treat HAE, Takeda offers Takhzyro, a medication that can be used on-demand and as a preventative therapy, administered at home through a subcutaneous injection.  Salome explains, "Hereditary angioedema, or HAE, is a rare genetic disorder with a prevalence of one in 50,000. It can cause very painful, unpredictable swelling attacks that can occur in the throat, abdomen, hands, feet, and face. And as you can imagine, a throat attack could be potentially life-threatening. There are different triggers for these attacks. Some can just be stress and that could be positive stress like a wedding or going to prom or an illness and others. It can be quite limiting when you have to live thinking if I do something, is that going to trigger an attack? The symptoms can change over time, and HAE may not necessarily look the same for each person. Typically, people with HAE are missing an important protein in their blood called a C1 inhibitor. Either they're missing it or have very low levels, and it just may not work the way it should." "For people who have never heard of HAE, things get a lot more difficult because they rely on their physician, who may or may not be aware of this very rare disease and consider it part of the differential diagnosis. So it is not uncommon to hear patients talk about going for years before they ever got their diagnosis and that they were experiencing symptoms during that time, going to the emergency room, and maybe even being misdiagnosed with another condition until they finally saw someone who thought, oh, you know what? We should screen you for HAE." "Screening is really just a blood test. So, you would screen for a C4 level, which would be low or normal. If you're thinking about whether this could be HAE, then you would go ahead and check a C1 inhibitor level and a functional C1 level, and then those would be low as well. It's really about educating people, though, to consider it as part of the differential diagnosis."  #Takeda #HAE #HereditaryAngioedema #RareDisease takeda.com Listen to the podcast here

Join us for an engaging episode with Dr. Leslie Wong, Senior Medical Director of Medical Specialties at Intermountain Health. Dr. Wong shares insights into his background, impactful changes in the past year, current healthcare trends, and growth strategies for the next 12-24 months. Tune in to gain valuable perspectives on medical specialties and the evolving landscape of healthcare.

This episode's Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow' Sustainability Campaign, and how you can get involved: CLICK HERE---Episode Overview: What if we could transform healthcare for underserved communities by empowering independent practices to deliver value-based care? Our next guest, Dr. Michael Poku, is doing just that as Chief Clinical Officer at Equality Health.With extensive experience in clinical leadership, medical informatics, and value-based care models, Dr. Poku is spearheading a transformative approach that equips independent practices with technology, care coordination, and hands-on support to optimize whole-person care for diverse populations, especially those on Medicaid.Join us as Dr. Poku shares his journey and Equality Health's mission to eradicate healthcare disparities via their pioneering model that is driving better outcomes, reducing costs, and delivering value-based care for diverse communities. Let's go!Episode Highlights:Equality Health's mission to eradicate healthcare disparities by empowering independent practices to deliver value-based care for underserved, diverse communities, especially those on Medicaid.Dr. Poku's background spanning clinical leadership, medical informatics, and expertise in value-based care models positions him uniquely to drive Equality Health's innovative approach.Equality Health provides independent practices with technology, care coordination tools, and hands-on support to optimize performance and outcomes in value-based care.The transformative model meets practices where they are, helping under-resourced clinics adopt value-based care to improve patient health while increasing financial sustainability.Dr. Poku's vision for leveraging AI, predictive analytics and a "do good, do well" mentality to bring greater health equity through data-driven, whole-person care.About our Guest: Dr. Michael Poku is an accomplished healthcare executive with extensive experience in clinical leadership, medical informatics, and value-based care. Prior to serving as the Chief Clinical Officer for Equality Health, he was Senior Medical Director at Oak Street Health, overseeing multiple clinical teams and driving innovative models of value-based care delivery, resulting in improved patient outcomes and increased operational efficiency. His expertise lies in enterprise-wide strategy, clinical delivery innovation, medical cost management, and the development of technology-enabled and data-informed clinical tools and processes.Dr. Poku was also previously Chief Medical Officer at NextHealth Technologies through the company's acquisition by Softheon Technologies, where he formulated and executed clinical and product strategies for an AI-powered healthcare analytics platform. During his tenure, he successfully led client success, sales, and ongoing product development, optimizing informatics processes to enable health plan customers to achieve maximum ROI from their analytics investments. Dr. Poku also served as Senior Medical Director at Signify Health, where he developed and led clinical strategies and execution for complex care management and at-home wellness programs.Dr. Poku continues to practice, holding academic faculty positions at various health systems. Throughout his career, Dr. Poku has authored numerous publications on topics such as care coordination, healthcare analytics, patient relationship management, and several topics at the intersection of healthcare and technology.Dr. Poku received his MD from Vanderbilt University School of Medicine and holds an MBA from Harvard Business School. He trained at Johns...

On this episode of OccPod, Erin and Dr. Nabeel talk with the incoming Presidential Line of ACOEM. We welcome our guests, Drs. Tanisha Taylor, Laura Gillis, and Jill Rosenthal.  Dr. Tanisha Taylor is Senior Medical Director for RWJBH Employee Health and Wellness, New Jersey. Dr. Taylor received her MD from New York Medical and her MPH from Yale University. Dr. Taylor is the current President-Elect of ACOEM. She joined the College in 2005, and served as Young Physician Director from 2013 – 2016, after which she was a Director on the Board for several years. She has been active on the American Occupational Health Conference Planning Committees and currently serves on the Council on Governmental Affairs and chairs the Vaccine Workgroup. Dr. Gillis is currently the Chief Medical Officer at Union Pacific Railroad.  Her previous positions include serving as a US Naval Flight Surgeon, a private practice physician and business owner, the US Federal Maritime Surgeon, and a Medical Director at BNSF Railway. Dr. Gillis is currently ACOEM's Vice President.  She has held multiple roles in ACOEM, including Chair of the Council on Membership Engagement, Chair of the Transportation Section, and has been member of the ACOEM Board of Directors since 2019. Dr. Jill Rosenthal is the Chief Medical Officer at Zenith Insurance, a Fairfax Financial Company.  She is also an Affiliate Assistant Professor at the University of South Florida Occupational Medicine Residency Program and the past Chairperson of the Florida Prescription Drug Monitoring Program Foundation Board. Dr. Rosenthal has served as the Medical Director for General Motors, Evanston-Northwestern Hospital's Employee Health Department, and two Johnson and Johnson companies.  She is the current Treasurer and incoming Vice President of ACOEM and chairs ACOEM's Justice, Equity, Diversity, and Inclusion committee.  In May, Dr. Taylor will be installed as ACOEM President, Dr. Gillis ascends to President Elect, and Dr. Rosenthal becomes ACOEM's Vice President.  Please join us at the 108th American Occupational Health Conference – AOHC – May 19-22, at Lowes Royal Pacific Resort in Orlando, FL, where our incoming leaders take office! Learn more about the conference and register today at acoem.org/aohc. 

Today you're getting a masterclass from one of the most renowned and respected experts on alcohol.She's here to give you the latest research and science of how alcohol impacts your body, brain, and mind. She's going to give you facts, dispel myths, and help you be informed about the decisions you are making when it comes to your mental, physical, and emotional health when it comes to alcohol consumption.Dr. Sarah Wakeman is Senior Medical Director of Substance Use Disorder at Harvard's Mass General Brigham, ranked the #1 research hospital in the world. She's also an Associate Professor of Medicine at Harvard Medical School and the Program Director of Mass General Substance Use Addiction Services.How much is TOO much alcohol?Is some alcohol healthy?What happens to your brain when you drink?And how do you help someone you love who drinks too much?Get the latest research so that you make the most informed decisions about the role alcohol plays in your life. For lots more resources, click here for the podcast episode page. Connect with Mel: Get Mel's free 29-page workbook to make this your best yearWatch the episodes on YouTubeFollow Mel on Instagram The Mel Robbins Podcast InstagramMel's TikTok Sign up for Mel's newsletter Disclaimer

The Fellowship of the Snow kept it interesting this year…both on and off the slopes!  On this episode, Patrick Georgoff discusses the Western Trauma Association's updated resuscitative thoracotomy algorithm with Ron Tesoriero, the results of a WTA multicenter trial exploring chest tube irrigation for the prevention of retained hemothorax with Thomas Carver, and prehospital blood administration with Juan Duchesne.   ** Algorithms and papers are pending final review and are therefore not available to link to this episode.   Ron Tesoriero, MD: Associate Professor of Surgery, Director of the Acute Care Surgery Fellowship, and Co-Director of the SICU at UCSF. Thomas Carver, MD: Associate Professor of Surgery, Director of the Acute Care Surgery Fellowship, and Senior Medical Director of Critical Care Services at the Medical College of Wisconsin.   Juan Duchesne, MD: Professor of Surgery and Chief of Trauma and Acute Care Surgery at Tulane university.    Resuscitative Thoracotomy: The Who (Episode 475): https://app.behindtheknife.org/podcast/big-t-trauma-series-ep-14-ed-thoracotomy-the-who  Resuscitative Thoracotomy: The How (Episode 476): https://app.behindtheknife.org/podcast/big-t-trauma-series-ep-15-ed-thoracotomy-the-how Innovation Lifeflow (Episode 642): https://app.behindtheknife.org/podcast/innovations-in-surgery-lifeflow We now have over 725 episodes!  The easiest way to find specific topics or episodes is on our website https://app.behindtheknife.org/home or on our new Apple/Android app.  You can search or browse by topic, podcast series, etc., making it much easier to navigate than podcast players.   iOS: https://apps.apple.com/us/app/behind-the-knife/id1672420049 Android: https://play.google.com/store/apps/details?id=com.btk.app PREMIUM BUNDLE: https://app.behindtheknife.org/bundle/95 Please email hello@behindtheknife.org to learn more about our premium bundle and institutional discounts.  Premium Bundle Includes: General Surgery Oral Board Audio Review Trauma Surgery Video Atlas Colorectal Surgery Oral Board Audio Review Surgical Oncology Surgery Oral Board Audio Review Vascular Surgery Surgery Oral Board Audio Review Cardiothoracic Surgery Surgery Oral Board Audio Review

Since February is cardiovascular health awareness month, it's an important time to correct the record on just who is at risk of heart disease. It's not just a male health issue. Heart disease is the leading cause of death for women and men in Utah and across the country. In this episode of Utah Weekly Forum, Guest Host Rusty Keys is joined by Dr. Blake Gardner, Senior Medical Director for Cardiovascular Medicine with Intermountain Health. Dr. Gardner explains what men and women need to know about their individual heart health risk factors and how Primary Care Physicians can help  identify ways to create an enjoyable and heart healthy lifestyle. For more information, visit "Heart Health" on Intermountainhealth.org

Keith Dugger, longtime Rockies' head athletic trainer and senior medical director,  joins the Inside Athletic Training podcast to talk about his more than 20-year career with the Colorado Rockies, what it was like becoming the team's second head athletic trainer in club history, working for an expansion team, navigating life in the minor leagues, his best advice for young athletic trainers, and much more. For more information about PBATS and athletic training, visit pbats.com.

Sarita Mohanty, MD, MPH, MBA, President and CEO of The SCAN Foundation, shares their goal of improving the health and well-being of vulnerable populations. Learn how this grant making and impact investing organization supports older adults in home and community. About Sarita Sarita A. Mohanty, MD, MPH, MBA, serves as the President and Chief Executive Officer of The SCAN Foundation. The SCAN Foundation is an independent public charity that envisions a society where every older adult has the choices and opportunity to age well. Its mission is to ignite bold and equitable changes in how older adults age in both home and community. Previously, Sarita served as the Vice President of Care Coordination for Medicaid and Vulnerable Populations at Kaiser Permanente. Sarita was formerly Assistant Professor of Medicine at USC; Chief Medical Officer of COPE Health Solutions, a health care management consulting company; and Senior Medical Director at L.A. Care, the largest U.S. public health plan. Sarita completed her Internal Medicine residency at Beth Israel Deaconess Medical Center and research fellowship at Harvard Medical School. She earned her MD from Boston University, MPH from Harvard University, and MBA from UCLA. She completed undergraduate work at UC Berkeley. She currently is an Associate Professor at the Kaiser Permanente Bernard J. Tyson School of Medicine and is a practicing internal medicine physician with Kaiser Permanente. Sarita enjoys international travel, tennis, and spending time with her husband, three kids, and her dog, Apollo. Key Takeaways Americans do not have an accessible system of care. The infrastructure does not serve all populations equitably. There is a lot of fragmentation and a lack of care coordination and seamless focus on the individual. Vulnerable populations include lower income older adults and communities of color, and those in underrepresented geographies. We need more inclusive, equitable policies with private sector investment and integrated community support. Technology solutions are not being created equitably to address health disparities and access to quality care. In the next years, next 10 years, we will have more adults than children in the US. We need to invest in older adults so they can contribute effectively to society. The narrative on aging is starting to shift, yet still wrought with stigma and discomfort. Older adults need to be viewed as valued, actively contributing members of our communities, rather than framing them as a burden. Intergenerational housing models are a growing trend. Older adults and people with disabilities, caregivers and their families, live in independent living units clustered around shared spaces in exchange for labor for caregiving, receiving good wages, childcare and other benefits. There's not enough workforce to support the growing aging demographic, so intergenerational constructs will be critical.

In this episode, join Damanjeet Chaubey, Senior Medical Director and Vice President of Clinical Affairs at Clover Health, as he provides insights into his background and expertise in healthcare leadership. Damanjeet discusses the prominent issues shaping healthcare in 2024, expressing his excitement and concerns, and offers valuable perspectives on the essential qualities for effective healthcare leadership in the next 2-3 years.

In this episode, join Damanjeet Chaubey, Senior Medical Director and Vice President of Clinical Affairs at Clover Health, as she provides insights into her background and expertise in healthcare leadership. Damanjeet discusses the prominent issues shaping healthcare in 2024, expressing her excitement and concerns, and offers valuable perspectives on the essential qualities for effective healthcare leadership in the next 2-3 years.

In this episode, join Damanjeet Chaubey, Senior Medical Director and Vice President of Clinical Affairs at Clover Health, as she provides insights into her background and expertise in healthcare leadership. Damanjeet discusses the prominent issues shaping healthcare in 2024, expressing her excitement and concerns, and offers valuable perspectives on the essential qualities for effective healthcare leadership in the next 2-3 years.

Unlike traditional pain management, ReActiv8 therapy uniquely addresses chronic low back pain by restoring neuromuscular control and functional spine stability. In this episode, Dr. Chris Gilligan, MD, MBA, Executive Medical Director, Mass General Brigham Global Advisory, Senior Medical Director of Periprocedural Services, Director of Brigham and Women's Spine Service Line, Chief - Division of Pain Medicine, Brigham and Women's Hospital, discusses the groundbreaking five-year data on ReActiv8 therapy for chronic low back pain, offering insights into this transformative approach and its impact on patients' lives. Chris delves into the significant findings from his research, shedding light on the ReActiv8 therapy's effectiveness in addressing chronic low back pain and improving patients' quality of life. He provides an in-depth overview of the research, covering the methodology, patient demographics, and the remarkable outcomes achieved over the five-year study period. Dr. Gilligan also addresses the implications of the findings for payers, providers, and patients, offering a holistic perspective on the therapy's clinical and economic significance. Join Chris and Saul as they uncover the remarkable impact of this novel therapy and explore its broader implications for patients, physicians, and payers in the healthcare ecosystem. Resources:  Watch this amazing interview here. Connect with and follow Chris Gilligan on LinkedIn here. Learn more about ReActiv8-B Trial 3-Year Patient Outcomes Data here. Listen to Dr. Chris's previous interview. Visit the Mainstay website here.

Today's guest is Aaron Chamberlain, Senior Medical Director of the Musculoskeletal Clinical Program at Intermountain Health. Intermountain is a US-based not-for-profit healthcare system with over 350 clinics and 30 hospitals in the Intermountain West, located in Salt Lake City, Utah. Aaron joins us on the program today to talk about the biggest challenges facing healthcare leaders when it comes to driving patient access and improved outcomes. In conversation with Emerj Senior Editor Matthew DeMello, Aaron addresses the problem of tech debt and the role that emerging generative AI capabilities can play in ensuring that doctors are spending more time interfacing with patients than in tedious administrative tasks. If you've enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

This episode recorded live at the 2023 Becker's Payer Issues Roundtable in Chicago features Dr. Catherine Brisland, Senior Medical Director, Utilization Management, UPMC Health Plan. Here, she discusses her background & insights into her current role, the growth strategy of UPMC Health Plan, the biggest challenges facing health plans today, and more.

In this episode, David interviews psychiatrist, main researcher behind the first US Phase II trial of MDMA-assisted psychotherapy, and Senior Medical Director at MAPS Public Benefit Corporation: Dr. Michael Mithoefer; and Research Group Lead at the University of Zurich, and Principal Clinical Biomarker Lead at Boehringer Ingelheim, Katrin Preller, Ph.D. Mithoefer, Preller (and David) are speakers at the upcoming Psychedelic Medicine – Israel, which we all hope can go on as planned, December 10 - 13, in Tel Aviv. They discuss the conference and their current research: Preller's neuroimaging and work with psilocybin for alcohol use disorder, and Mithoefer (likely) being extremely close to seeing the FDA approve MDMA-assisted psychotherapy. He talks about how the therapeutic protocols for MDMA-assisted psychotherapy were created, what it's like to be so close to legalization, and how the next challenges will be accessibility and not minimizing therapy in favor of faster turnover.  They discuss neuroplasticity and whether or not it actually translates into something in humans; the concept of performing brain scans before a psychedelic experience to look for trauma biomarkers (and how this could actually result in savings over time); the excitement of seeing clinical work and neuroscience progressing in parallel; why integration frameworks need to be individualized; and the importance of embracing different therapeutic approaches. Click here to head to the show notes page.

The FDA Group's CEO, Nick Capman, sits down with Steve Knowles, MB.BS, M.R.C.P., M.F.P.M., Chief Medical Officer at Halozyme, a biopharmaceutical company bringing disruptive solutions to significantly improve patient experiences and outcomes for emerging and established therapies. They discuss advancements in drug delivery technology and the role of leadership in fostering innovation and addressing challenges in this field. Discussion points include: » Dr. Knowles's transition from a physician in the UK to Chief Medical Officer at Halozyme in San Diego. » The evolution in drug delivery systems, such as the shift from hospital-based treatments to self-administration of drugs at home and the introduction of auto-injectors and on-body devices for efficient, patient-friendly drug administration. » Addressing human factors and compliance to ensure products are user-friendly—and the importance of human factor studies in product development. » The advantages of subcutaneous drug delivery, including reduced side effects, improved pharmacokinetic profiles, and patient convenience. » How Halozyme's one-team approach fosters a culture of curiosity, flexibility, and feedback. » Aligning individual and organizational goals to drive innovation. Dr. Knowles has deep pharmacovigilance and medical affairs experience gained over a career spanning almost 20 years. Dr. Knowles joined Halozyme in January 2018 as Vice President, Drug Safety & Pharmacovigilance. He is responsible for the Medical, Regulatory and Drug Safety organizations. Prior to Halozyme, Dr. Knowles served as Senior Medical Director, Global Patient Safety and Benefit Risk Management at Eli Lilly & Co. where he led the global safety physician/scientist group responsible for overseeing the safety profiles and benefit risk management of medicines across all therapeutic areas and phases of development and supported numerous BLA and MAA submissions. During his 16 years at Lilly, he held positions in Medical Affairs and from 2005 to 2017 he held roles of increasing responsibility within Global Patient Safety. Prior to these roles, Dr. Knowles spent more than 17 years in clinical practice in the UK in both hospital-based and general practice roles. Dr. Knowles received his Bachelor of Medicine and Surgery degrees (MB.BS) from the University of Newcastle Upon Tyne and is a Member of the Royal College of Physicians (MRCP) and a Member of the Faculty of Pharmaceutical Medicine (MFPM). Who is The FDA Group? The FDA Group helps life science organizations rapidly access the industry's best consultants, contractors, and candidates. Our resources assist in every stage of the product lifecycle, from clinical development to commercialization, with a focus in Quality Assurance, Regulatory Affairs, and Clinical Operations. https://www.thefdagroup.com/

This episode's Community Champion Sponsor is Catalyst. To virtually tour Catalyst and claim your space on campus, or host an upcoming event: CLICK HERE---Episode Overview: During this episode, we spend time with Dr. Agim Beshiri, Chief Medical Officer of Nutromics, an international leader pioneering continuous diagnostic monitoring to transform personalized care. Bringing over 20 years of clinical and industry expertise, Agim is driven to advance patient-centric precision medicine. While together, Agim shares how Nutromics utilizes synthetic DNA sensors for real-time, first-order molecular recognition. Additionally, Agim unpacks the future of scaling personalized treatment through continuous multiplexed monitoring. We also discuss reinventing antiquated blood testing methodologies and paradigm shifts enabling preventative intervention. Join us as Agim outlines a vision for mimicking implanted diagnostic tools across diverse disease states and to gain inspiration from his dedication to elevating global standards of care through innovative diagnostics. Let's go! Episode Highlights:Agim brings deep medical affairs experience to transform diagnostic testingHow Nutromics uses synthetic DNA sensors for continuous, multiplexed monitoringWays in which Nutromics enables real-time precision dosing adjustments and early interventionsAgim envisions scaling continuous diagnostics across diverse disease statesHow Agim exemplifies commitment to profoundly advancing personalized medicine About our Guest: Agim Beshiri, M.D., is the Chief Medical Officer (CMO) at MedTech startup Nutromics. His passion is in elevating the standard of care for all patients. With over 20 years' experience in the IVD field both in the clinical setting and industry. Dr Beshiri developed methods and collaborations that enabled patient-centric application of diagnostics addressing underserved patients in disease states from cardiology to oncology.A leading industry expert in developing a medical affairs organization and driving medical research and education. With a broad background in internal medicine, hematology, general cardiology, and laboratory medicine, Dr Beshiri initiated and collaborated on research programs resulting in over 800 research collaborations and over 1000 publications.Prior to Nutromics, Dr Beshiri was Senior Medical Director at Abbott Laboratories where he developed supporting their Diagnostics organization for over 16 years. His clinical experience includes the Brooke Army Medical Center in Texas, the 452nd Combat Support Hospital in Wisconsin and Aurora/Advocate Clinical Laboratories in Wisconsin and Illinois, and South-eastern Europe.Dr. Beshiri is a member of several organizations, including the American Medical Association, American Heart Association, European Society of Cardiology, International Society for Laboratory Hematology, European Hematology Association, American Society of Hematology, and American Society of Clinical Oncology. He has also served on guideline subcommittees for the Clinical and Laboratory Standards Institute.Links Supporting This Episode:Nutromics Website: CLICK HEREDr. Agim Beshiri LinkedIn page: CLICK HERENutromics Twitter page: CLICK HERE Mike Biselli LinkedIn page:

Radiosensitizers have emerged as potential game-changers in head and neck cancer therapy. A diverse group of compounds, radiosensitizers enhance radiation therapy's impact on tumor cells. Ongoing research seeks radiosensitizers that augment radiotherapy's efficacy without increasing toxicity, offering exciting prospects for the APAC region and beyond.Our new APAC Edition host Lance Eminger, Executive Director of Business Development is joined by Dr. Juan Manuel Carrera, Senior Medical Director at Syneos Health to discuss what radiosensitizers are and how they work—highlighting the potential of new radiosensitizers to redefine cancer treatment, fostering better results with fewer side effects.The views expressed in this podcast belong solely to the speakers and do not represent those of their organization. If you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you'll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision-making and investment. You can find it all at insightshub.health. Like what you're hearing? Be sure to rate and review us! We want to hear from you! If there's a topic you'd like us to cover on a future episode, contact us at podcast@syneoshealth.com.

This episode features Dr. Johanna Vidal-Phelan, Clinical Assistant Professor of Pediatrics at the University of Pittsburgh School of Medicine & Senior Medical Director of Quality and Pediatrics for UPMC Insurance Division. Here she discusses her background, top priorities right now, how her organization will evolve over the next couple years, and one change that she or her team has made that yielded great results.

Hosts: Leah Murray and Derek Brown  Last week we got some great news for all mothers and soon-to-be mothers, as the FDA approved the first postpartum depression pill. Dr. Sean Esplin, Senior Medical Director for Women Health at Intermountain Health discusses the new drug and how it can help mothers suffering from postpartum depression. See omnystudio.com/listener for privacy information.

Hosts: Leah Murray and Derek Brown Utah Supreme Court On Utah's Abortion Trigger Ban The Utah Supreme Court heard arguments today over whether Utah's abortion trigger law should stay on hold, or take effect, while the case is sorted out in the courts. KSL Legal Analyst Greg Skordas joins the show to go over what was discussed today in court. President Biden's Utah Visit & Grand Canyon Designation President Biden is set to visit Utah on Wednesday. We speak with Ben Anderson, Utah Democratic Party Communications Director, on what the President's plans are while he visits Utah. UDOT Uses Geofoam In West Davis Highway Construction Many people are familiar with styrofoam from seeing it in packages to keep products safe. UDOT is using a similar material called Geofoam to build a ramp for the West Davis Highway Construction. We speak with Rex Harris, Project Director for the West Davis Highway to discuss why they are using it, and the benefits of it. Nuclear Project Coming To Utah Utah is getting ready to build a new Carbon Free Power Project facility using nuclear energy. Mason Baker, CFPP President, joins the show to discuss the new facility, and why Utah and other western states can benefit from Nuclear Power. Supreme Court Revives Biden's Ghost Gun Restrictions The Supreme Court of the United States revived the Biden administration's restrictions on ‘ghost guns' in a ruling today. Legal Affairs Reporter for The Hill Zach Schonfeld talks about the decision by the court, and how this is a temporary win for President Biden. Judge Wants To Hear Both Sides In Trump's Jan. 6 Case The judge in the January 6th case has asked to hear from both sides in person before deciding whether to issue an order restricting Trump's ability to talk about the evidence in the case. ABC News National Correspondent Steven Portnoy joins the show to discuss the latest in the case. FDA Approves First Postpartum Depression Pill Last week we got some great news for all mothers and soon-to-be mothers, as the FDA approved the first postpartum depression pill. Dr. Sean Esplin, Senior Medical Director for Women Health at Intermountain Health discusses the new drug and how it can help mothers suffering from postpartum depression. What The UFO Hearings Told Us Congress has been holding bipartisan hearings pushing to declassify government documents related to unidentified anomalous phenomena. We call Marik Von Rennenkampff, opinion contributor for The Hill, to discuss his latest article on the ‘looming UFO scandal'.See omnystudio.com/listener for privacy information.

This week on the CBS News Weekend Roundup with host Stacy Lyn, former President Trump was in court for his third indictment. CBS's Natalie Brand has the details and our Scott MacFarlane gives us a look inside the courtroom. Correspondent Jonathan Vigliotti has the latest on a woman who was abducted and locked up in a makeshift cinderblock cell in a garage in Oregon. And in the Kaleidoscope, Stacy Lyn talks about the rise in HIV cases among black women with Dr. Toyin Nwafor, the Senior Medical Director for HIV Prevention at ViiV Healthcare, See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Are our healthcare heroes silently burning out while we rely on them to save lives? This conversation is for you if you know someone or work in healthcare. LouAnne Giangreco, M.D. is a consultant and executive coach through her company, June Rose Consulting. Dr. Giangreco has practiced emergency medicine, urgent care medicine, and occupational medicine throughout Upstate New York. In addition, she served in leadership roles within a number of settings in the provider, payer, and start-up spaces.  She served as Chief Medical Officer for Five Star Urgent Care, VP and Chief Medical Officer of Health Care Improvement for Excellus BlueCross Blue Shield, and System Chief Medical Officer of Cayuga Health System in Upstate New York. Most recently, she served as a Senior Medical Director of Medical Affairs at BlueCross BlueShield of Rhode Island. She is board certified in Emergency Medicine and a fellow of the American College of Emergency Physicians. Dr. Giangreco completed a residency program in Emergency Medicine at Upstate Medical University. She earned her medical degree from Albany Medical College. Contact Dr. LouAnne www.linkedin.com/in/louanne-giangreco-md-facep Instagram-@louannemd --- Send in a voice message: https://podcasters.spotify.com/pod/show/urcaringdocs/message

Sana Aslam discusses a transition from academic clinical medicine to industry with Dr. Rita Gandhi, Senior Medical Director of Huntington's Disease Clinical Development at Genentech. They discuss types of industry jobs, the appeal of a career in industry, how to be prepared for an industry job, and the learning curve of making the transition. 

June 21 Today on the Conference channel, it's an Interview in Action live from HIMSS 2023 with Tahir Haque, MD, Senior Medical Director at Biofourmis. What are the four main components of delivering successful care in the home? What challenges do health systems face when trying to push care outside of their four walls? How does Bioformis adapt its solutions to cater to the specific requirements of each community, and what role does technology play in enabling equitable care at home?"The Patient Experience - A Technology Perspective" is a live webinar that explores the intersection of healthcare and technology, focusing on enhancing the patient experience. As healthcare systems prioritize patient-centered care, leveraging technology becomes crucial. Join us on July 6th, 1:00 PM ET and join the discussion! Register Here. - https://thisweekhealth.com/leader-series-the-patient-experience-a-technology-perspective/Subscribe: This Week HealthTwitter: This Week HealthLinkedIn: Week HealthDonate: Alex's Lemonade Stand: Foundation for Childhood Cancer

One challenge in developing treatments for rare diseases is finding enough people with the condition to mount valid clinical trials.  Databases that contain diagnostic codes for specific conditions can help, but those miss people who may have the condition but have yet to be conclusively diagnosed.  That's where Verana Health comes in, a digital health company that uses AI to mine its data network of more than 20,000 healthcare providers and the clinic notes they make about patient encounters. “If you wanted to find somebody with a specific genetic defect, or a specific condition for which a diagnostic code doesn't even exist, clinic notes represent really the only place you could discover that information,” explains Dr. Michael Mbagwu, an ophthalmologist and Verana's Senior Medical Director. Verana partners with the American Academy of Ophthalmology, the American Academy of Neurology and the American Urologic Association to manage their clinical registries which were built to improve quality of care, answer research questions and help physicians report quality metrics. Join host Michael Carrese for an exploration of the ways medicine is being changed by the ever-growing amount of data available and the new technologies which allow clinicians and others to analyze and use all of that information. “Some of the things that we just assumed were never possible or were kind of hopeless endeavors are now possible for the first time thanks to AI.” Mentioned in this episode: https://www.veranahealth.com/

Today on Boston Public Radio: We began the show by talking about our fascination with scandal in the British royal family – and how it distracts us from the fraying of democracy. EJ Dionne weighed in on House Speaker Kevin McCarthy's contentious election for House Speaker last week, and pro-Bolsonaro riots in Brazil's Capital with claims of election fraud. Dionne is a columnist for the Washington Post. He's also a senior fellow at The Brookings Institution. His latest book is “100% Democracy: The Case For Universal Voting.” Jim Aloisi and Stacy Thompson shared their hopes on what Gov. Maura Healey should prioritize in Mass. transit, from safety at the MBTA to strengthening the state's roads and bridges. Aloisi is a former transportation secretary, a member of the Transit Matters Board, and a contributor to Commonwealth Magazine. Thompson is the executive director of the Livable Streets Alliance. Drs. Allison Bryant and Nicole Smith explained how a local doula program is trying to combat maternal mortality disparities. Dr. Bryant is a maternal fetal medicine specialist at Mass General Hospital and is Senior Medical Director for Health Equity Quality and Patient Experience. Dr. Smith is a maternal fetal medicine specialist at Brigham and Women's Hospital. Revs. Irene Monroe and Emmett G. Price III shared their thoughts on how Congressmembers' religions don't reflect the diverse religions in modern America, and a controversial firing of a professor who showed art of the Prophet Muhammed in a college course. Monroe is a syndicated religion columnist and the Boston voice for Detour's African American Heritage Trail. Price is founding pastor of Community of Love Christian Fellowship in Allston, and the Inaugural Dean of Africana Studies at Berklee College of Music. Together they host GBH's “All Rev'd Up” podcast. Richard Blanco shared a few poems from “Let Me Say This: A Dolly Parton Poetry Anthology,” and discussed Dolly Parton's avid fanbase. Blanco is the fifth Presidential Inaugural Poet in U.S. history and the first Poet Laureate of Miami-Dade County. His latest collection is “How To Love A Country.” We ended the show by talking with listeners about the latest COVID surge.